AbbVie Inc. (ABBV) vs Johnson & Johnson (JNJ)
JNJ leads on 8 of 15 compared metrics.
A side-by-side comparison of AbbVie Inc. and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABBV vs JNJ
growth of $100 · last 14yABBV +544.8%JNJ +238.8%ABBV compounded faster
ABBV JNJ
ABBV vs JNJ: by the numbers
- •JNJ is the larger company ($579.83B vs $402.35B market cap).
- •JNJ trades at the lower earnings multiple (27.85 vs 111.67 P/E).
- •JNJ converts more revenue to profit (21.83% vs 5.79% net margin).
- •ABBV grew revenue faster over the past five years (4.59% vs 2.99% CAGR).
- •ABBV pays the higher dividend yield (2.96% vs 2.18%).
Which is better, ABBV or JNJ?
Metric tally: ABBV 7 · JNJ 8It depends on what you're optimizing for:
ValueJNJ(lower P/E)
GrowthABBV(faster 5Y revenue CAGR)
IncomeABBV(higher dividend yield)
QualityJNJ(higher ROIC)
Valuation
| Metric | ABBV | JNJ |
|---|---|---|
| P/E ratio | 111.67 | 27.85● |
| Forward P/E | — | 18.87 |
| P/S ratio | 6.43 | 6.11● |
| P/B ratio | 14.69 | 7.25● |
| PEG ratio | — | 0.21 |
| EV / EBITDA | 27.63 | 18.71● |
| FCF yield | 5.17%● | 3.02% |
Profitability
| Metric | ABBV | JNJ |
|---|---|---|
| Gross margin | 70.68%● | 69.12% |
| Operating margin | 27.60%● | 26.87% |
| Net margin | 5.79% | 21.83%● |
| ROE | 13.23% | 25.92%● |
| ROIC | 12.97% | 13.71%● |
Dividends
| Metric | ABBV | JNJ |
|---|---|---|
| Dividend yield | 2.96%● | 2.18% |
| Payout ratio | 284.39% | 47.51% |
Growth (annualized)
| Metric | ABBV | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 4.59%● | 2.99% |
| EPS CAGR (5Y) | -2.79% | 11.51%● |
| FCF CAGR (5Y) | 3.24%● | -2.38% |
| Total return CAGR (5Y) | 18.95%● | 10.93% |
Frequently asked
- Which is better, ABBV or JNJ?
- It depends on your goal. value: JNJ (lower P/E); growth: ABBV (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: JNJ (higher ROIC). Across all compared metrics, JNJ leads 8 to 7.
- Is ABBV or JNJ cheaper?
- On trailing earnings, JNJ is cheaper: ABBV trades at a 111.67 P/E and JNJ at 27.85.
- Which has grown faster, ABBV or JNJ?
- Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus JNJ at 2.99%.
- Does ABBV or JNJ pay a bigger dividend?
- ABBV yields 2.96% and JNJ yields 2.18% based on trailing dividends and the latest price.
- Is ABBV or JNJ more profitable?
- JNJ runs the higher net margin — ABBV at 5.79% versus JNJ at 21.83%.
- Which has been the better investment, ABBV or JNJ?
- Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus JNJ at 10.46%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioJohnson & Johnson P/E ratioAbbVie dividend yieldJohnson & Johnson dividend yieldAbbVie ROEJohnson & Johnson ROEAbbVie operating marginJohnson & Johnson operating marginAbbVie revenue growthJohnson & Johnson revenue growthAbbVie free cash flowJohnson & Johnson free cash flow
AbbVie & Johnson & Johnson appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.